Sunday, February 10, 2013

Conclusions: Therapeutic Potential of Novel Cannabinoid Receptors - Springer

Conclusions: Therapeutic Potential of Novel Cannabinoid Receptors - Springer

Abstract

For centuries the plants Cannabis sativa and Cannabis indica (commonly known as marijuana) have been used for recreational, religious, and medicinal purposes across diverse cultures. The first recorded attributes of Cannabis were on its potent therapeutic actions, which included analgesic, sedative, and anticonvulsant effects. In the 1930s Cannabis extracts were one of the most commonly prescribed medicines of the US pharmacopeia. Unfortunately, the early criminalization of the use of Cannabis resulted in a near 35-year stall in scientific research aimed at understanding and optimizing the therapeutic potential of its extracts. It was the isolation and chemical characterization of ∆9-tetrahydrocannabinol (THC) in 1964 as the first bioactive ingredient produced by Cannabis that revived the scientific community’s interest in further understanding and optimizing the unique therapeutic properties of phytocannabinoids (phyto-CB) (Mechoulam and Gaoni 1967)

No comments:

Post a Comment